图片来源:视觉中国界面新闻记者 |唐卓雅界面新闻编辑 |谢欣诺和诺德6月12日向界面新闻记者确认,诺和诺德中国肥胖症业务部副总裁张一帆将于6月30日离任。张一帆将于2025年7月1日正式加入灵北中国,就任新任总经理。另外,自6月12日起,诺和诺德中国肥胖症业务部与胰岛素组合并,成立肥胖症与糖尿病事业部(DOD)。肥胖症与胰岛素产品线的销售将由糖尿病事业部企业副总裁张辉负责,而肥胖症市场部将向市场部...
Source Link图片来源:视觉中国界面新闻记者 |唐卓雅界面新闻编辑 |谢欣诺和诺德6月12日向界面新闻记者确认,诺和诺德中国肥胖症业务部副总裁张一帆将于6月30日离任。张一帆将于2025年7月1日正式加入灵北中国,就任新任总经理。另外,自6月12日起,诺和诺德中国肥胖症业务部与胰岛素组合并,成立肥胖症与糖尿病事业部(DOD)。肥胖症与胰岛素产品线的销售将由糖尿病事业部企业副总裁张辉负责,而肥胖症市场部将向市场部...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.